Correction to: Biologic Drug Quality Assurance to Optimize HER2+  Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

The article Biologic Drug Quality Assurance to Optimize HER2+  Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3,
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research